Sun Pharmaceutical Industries has re-appointed Dr. Pawan Goenka as an Independent Director for a second five-year term, effective May 21, 2026. Shareholders must approve the appointment. Ms. Rama Bijapurkar will retire as an Independent Director on May 20, 2026, upon completing her first term. The Board expressed appreciation for her contributions.
Board Re-appointments and Retirement
The Board of Directors at Sun Pharmaceutical Industries has approved the following key changes:
Re-Appointment of Dr. Pawan Goenka
Dr. Pawan Goenka has been re-appointed as a Non-executive and Independent Director for another term of five years. The new term is set to commence on May 21, 2026, and will continue until May 20, 2031. This appointment is subject to shareholder approval. He will continue to serve as the Lead Independent Director.
Retirement of Ms. Rama Bijapurkar
Ms. Rama Bijapurkar will retire from her position as an Independent Director on May 20, 2026, after completing her initial term. She has decided not to seek reappointment. The Board acknowledges her significant guidance and contributions during her tenure.
Dr. Pawan Goenka’s Background
Dr. Goenka currently serves as the Chairperson of the Indian National Space Promotion and Authorization Centre (IN-SPACE), under the Department of Space, Government of India. He previously retired from Mahindra as Managing Director and CEO on April 1, 2021. His extensive experience includes roles at General Motors R&D Centre and Mahindra & Mahindra Ltd.
Recognitions and Affiliations
Dr. Goenka was awarded the Padma Shri in 2025. He is also the Chairman of the Board of Governors of IIT Madras and serves as an Independent Director on the Board of Bosch Limited. Additionally, he chairs the Steering Committee for Advancing Local value-add and Exports (SCALE).
Source: BSE
